RankAlpha logo
Back to Rankings

IMTX

ImmaticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
October program-specific data could broaden confidence in the PRAME franchise, while a positive randomized SUPRAME result could support the planned 2027 BLA. The company reported $448.2 million of cash and other financial assets at June 30 and projected cash reach into 2028.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -11.4.
What can break
October IMA203CD8 and IMA402 updates are early-stage data and may not show durable benefit or an acceptable safety profile.
Momentum
17
Value
41
Sentiment
73
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.50 · Bull $13.50 · Bear $4.50Analysis 2026-10-02; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-02 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $16.86
Why
Momentum17 · Δ7d -2.1
Value41 · Δ7d -0.1
Sentiment73 · Δ7d -11.4
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Confirming evidence

  • • Sentiment remains the lead driver in the composite, 7D delta -11.4.

Contradictions & invalidation

  • • October IMA203CD8 and IMA402 updates are early-stage data and may not show durable benefit or an acceptable safety profile.
  • • Rising trial and commercialization-preparation spending could shorten the projected runway or require additional financing. Company Q2 release
  • • SUPRAME remains unproven in a randomized trial, and slower-than-modeled endpoint events could affect timing.

Catalyst clock

2026-10-23

IMA203CD8 Phase 1 data at ESMO

Lead driver: Sentiment · See AI snapshot
Momentum
17
8% active weight
Current posture
7d trendSoftening
Δ7d
-2.1
Δ21d
-13.1
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.4
Sentiment
73
45% active weight
Current posture
7d trendSoftening
Δ7d
-11.4
Δ21d
-3.8
Why this grade

Composite grade C. Momentum 17.0 / Value 40.6 / Sentiment 73.5

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-02. Scenario method

B+
Bull case
25%
Probability
Target price
$13.50
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$1.09B
Beta
1.36
Shares Out
149.64M
P/E (TTM) · Derived
-4.0
P/S (TTM)
11.93
P/FCF (TTM) · Derived
-3.85
Rev YoY
+98.0%
EPS YoY
-19.0%
Gross Margin
-
Op Margin
-555.6%
Net Debt
-$532.85M
Current Ratio
7.54
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data